Did Aramco Venture Review Just Shift Dow (DOW) Investment Narrative?

• Dow Inc. is reviewing options for its stake in a roughly US$20b chemicals venture with Saudi Aramco, as part of a broader portfolio refresh during a prolonged chemicals downturn.
• The company’s Q2 2026 update highlighted stronger sales, higher EBITDA and improved earnings per share, which sit alongside cost and asset actions as management reshapes Dow’s operating mix.
• The next question is how Dow’s portfolio review and recent Q2 performance could reshape the existing investment narrative for the business.

Compare Dow’s portfolio reshaping story with other materials and chemicals players by scanning our hand picked 33 high quality undervalued stocks that may be repositioning for the next phase of the cycle.

Dow Investment Narrative Recap

To own Dow, you need to believe the materials cycle eventually improves enough for its cost cuts, portfolio pruning and capital discipline to show through in cleaner earnings. The review of its roughly US$20b Saudi Aramco venture fits that story. It reinforces a shift toward higher cash generation and a simpler asset base rather than changing it.

The more immediate swing factor still looks like margins versus feedstock and energy costs. The biggest near term risk remains a weak macro backdrop that keeps volumes and pricing under pressure while Dow carries an unprofitable starting point and interest and dividends that are not fully covered by earnings.

The review of Dow’s stake in the Saudi Aramco chemicals venture matters most alongside plans to sell minority interests in select U.S. Gulf Coast infrastructure assets. Both processes point to a willingness to recycle capital out of lower return or non core positions and into debt reduction, operations or future projects when conditions improve.

For catalysts, investors are watching whether these moves translate into stronger cash flow and more room to fund Path2Zero and other projects without stretching the balance sheet. The risk is that if industry demand stays soft, asset sales and reviews improve flexibility but do not quickly fix margin pressure or Dow’s currently weak earnings coverage of interest and dividends.

Dow's current analyst storyline assumes revenue reaches US$44.6b and earnings reach US$2.1b by 2029, which implies 2.6% yearly top line growth and an earnings swing of US$3.4b from a loss of US$1.3b today to the forecast profit level.

Uncover why Dow's fair value indicates a 17% potential upside to its current price that could narrow quickly.

Exploring Other Perspectives

One alternate take on Dow focuses on decarbonization risk rather than short term margins. The most pessimistic analysts were only penciling in around 1.1% annual revenue growth to about US$42.7b and earnings of roughly US$1.6b by 2029 before this Aramco stake review. Their forecasts may shift meaningfully as this story develops.

Explore 4 other Dow fair value estimates, including one that suggests it could be worth just $29.00.

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Dow research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• See our latest analysis for Dow. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate Dow's overall financial health at a glance.

Looking For More Ideas Beyond Dow?

If the Dow story has you thinking about portfolio upgrades, it can help to widen the lens and scan for other companies with different risk and return profiles. The Simply Wall St Screener is built for exactly that, letting you filter by balance sheet strength, income focus or unloved opportunities that may not yet be widely followed.

• For investors who want potential upside without taking on excessive fragility, start with a curated set of companies that screen as more resilient in tougher conditions through the 11 resilient stocks with low risk scores.
• If capital preservation and business quality matter more to you than headline growth, use the list of solid balance sheet and fundamentals (23 results) to focus on firms that pair healthier finances with underlying fundamentals.
• When you prefer to hunt where fewer people are looking, you can surface under followed contenders with stronger metrics by scanning the 18 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com